BioGaia and Ferring extend licensing arrangement
Swedish probiotics specialist BioGaia has strengthened its relationship with biopharma group, Ferring Pharmaceuticals, via new licensing agreements that will see the Swiss firm distributing BioGaia products in European and Middle East countries.
Ferring has acquired the exclusive rights to sell BioGaia's Probiotic Drops in Ireland as well as the rights to sell BioGaia's Probiotic Drops and Tablets in Bahrain, Yemen, Qatar, Oman, Kuwait and United Arab Emirates.
"We are very happy to again expand the contract with Ferring in to these interesting markets. Ferring is taking the BioGaia brand to markets we have not been before and it is yet another step in our effort to build a global probiotic brand," said BioGaia president, Peter Rothschild.